Martin Forss

Martin Forss is an accomplished professional with extensive experience in various leadership roles across multiple companies. Currently, Martin serves as a Board Member at Dentognostics Holding AG, contributing to the development of aMMP-8 BIOMARKER Diagnostics for dental practices, and at Nextim plc, where the focus is on personalized neuromodulation therapy. Martin is also a Board Member and Chairman of the Board at Unident AB and has held the position of Chairman at Delete Group Oyj, a leader in environmental services in the Nordic region. Other significant roles include Board Member at Matrix Biotech AG, Plantui Oy, Entteri Professional Software Oy, and Turvatiimi PLC, as well as a former CEO of Oral Hammaslääkärit PLC. Martin holds an M.Sc in Finance & Accounting from Åbo Akademi University.